Please use this identifier to cite or link to this item:
Title: In-vivo antimalarial activity of aqueous root extract of Barringtonia acutangula in mice
Authors: Jayasinghe, Chanika D
Udagama-Randeniya, Preethi V
Ratnasooriya, W.D.
Keywords: Sri Lanka
Barringtonia acutangula
antimalarial activity
in vivo
Plasmodium yoelii
Issue Date: 2008
Publisher: Pharmacognosy Magazine
Citation: 10
Abstract: This study scientifically investigated the antimalarial activity of an aqueous root extract (ARE) of Barringtonia acutangula (L.) Gaertn. (Lecythidaceae), claimed to be used in malaria therapy in indigenous medicine in Sri Lanka. Three doses of the ARE (400, 800 and 1200 mg/kg), chloroquine or distilled water (DW) was orally administered for 3 consecutive days and the schizonticidal activity was examined in the Plasmodium yoelii murine model. The ARE exhibited dose dependent schizonticidal activity, the highest being recorded at 800 mg/kg dose. Oral administration of ARE at 800 mg/kg dosage significantly (p< 0.05) suppressed the parasitaemia by 60.88 % compared with the control. However, the ARE was 40 % less potent than chloroquine in the P. yoelii murine model. The ARE was well tolerated by mice over a period of 30 days showing no overt signs of toxicity, stress and hepatic (in terms of serum SGOT, SGPT levels), renal (in terms of serum creatinine, urea, Na+, K+ levels) and haematological toxicity. Slightly but a significant (p< 0.05) reduction in food and water intake was observed during 2nd and 3rd week of the experiment. In conclusion, the ARE of B. acutangula is orally active, relatively non-toxic and possesses antimalarial activity justifying the claims of indigenous medicine of Sri Lanka.
ISSN: 0973 1296
Appears in Collections:Department of Zoology

Files in This Item:
File Description SizeFormat 
20.pdfMain article146.38 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.